Plain language summary of disease activity and therapeutic response to pegcetacoplan for geographic atrophy identified by deep learning-based analysis of OCT
Authors
Lukas Scheibler
Sophie Riedl (ORCID: https://orcid.org/0000-0003-0003-0886)
Amir Sadeghipour (ORCID: https://orcid.org/0000-0003-2379-7895)
Julia Mai (ORCID: https://orcid.org/0000-0002-0528-9742)
Plain language summary of disease activity and therapeutic response to pegcetacoplan for geographic atrophy identified by deep learning-based analysis of OCT
Lukas Scheibler, Sophie Riedl, Amir Sadeghipour, Julia Mai et al.
Journal
Immunotherapy
Topics
Neurological Disease Mechanisms and Treatments
article
Plain language summary of disease activity and therapeutic response to pegcetacoplan for geographic atrophy identified by deep learning-based analysis of OCT
Lukas Scheibler, Sophie Riedl, Amir Sadeghipour, Julia Mai, Wolf‐Dieter Vogl, Gregor S. Reiter, Alex S. McKeown, Hrvoje Bogunović, Ursula Schmidt-Erfurth, Emma Foos
article en
Abstract
No abstract available for this paper.
Publication Tag
ImmunotherapyVol. 17(14)
Institutions
Kala Pharmaceuticals (United States) (US), HealthInsight (US), Medical University of Vienna (AT)